May 1, 2012
IOM Addresses Drug Safety
The Institute of Medicine issued a new report today, "Ethical and Scientific Issues in Studying the Safety of Approved Drugs." In the wake of problems that have arisen with drugs that needed to be pulled from the market, the IOM called for the collection and assessment of data about "a medication's benefit-risk profile throughout its entire 'life cycle' from approval until it is no longer marketed."
May 1, 2012 | Permalink
TrackBack URL for this entry:
Listed below are links to weblogs that reference IOM Addresses Drug Safety: